GPBAR1 and irritable bowel syndrome: This correlation between SCFA concentration and symptom severity suggests microbial metabolites contribute to IBS symptoms through mechanisms like GPCR activation and epigenetic effects, influencing inflammation, metabolism, and mucosal integrity.